Kevin A Peng1, Alan C Chu1, Chi Lai2, Tristan Grogan3, David Elashoff3, Elliot Abemayor4, Maie A St John5. 1. Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave CHS 62-132, Los Angeles, CA. 2. Department of Pathology and Laboratory Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada. 3. Department of Biostatistics, UCLA School of Public Health, 911 Broxton Ave, Los Angeles, CA. 4. Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave CHS 62-132, Los Angeles, CA; Jonsson Comprehensive Cancer Center, UCLA, 8-684 Factor Building, Los Angeles, CA; UCLA Head and Neck Cancer Program, 200 Medical Plaza, Suite 550, Los Angeles, CA. 5. Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave CHS 62-132, Los Angeles, CA; Jonsson Comprehensive Cancer Center, UCLA, 8-684 Factor Building, Los Angeles, CA; UCLA Head and Neck Cancer Program, 200 Medical Plaza, Suite 550, Los Angeles, CA. Electronic address: mstjohn@mednet.ucla.edu.
Abstract
PURPOSE: We sought to examine prognostic and therapeutic implications, including cost-effectiveness, of elective neck dissection in the management of patients with clinically-determined T1N0 oral tongue carcinoma. MATERIALS AND METHODS: A retrospective review of patients with cT1N0 oral tongue squamous cell carcinoma who underwent surgical extirpation of primary tumor, with or without elective neck dissection, at UCLA Medical Center from 1990 to 2009 was performed. Cox proportional hazards regression was used to assess effects of variables on time to first loco-regional recurrence. A healthcare costs analysis of elective neck dissection was performed by querying the SEER-Medicare linked database. RESULTS: Of the 123 patients identified with cT1N0 squamous cell carcinoma of the oral tongue, 88 underwent elective neck dissection at the time of tumor resection while 35 did not. For all patients, disease-free survival at 3, 5, and 10 years was 93%, 82%, and 79%. Of the 88 patients undergoing elective neck dissection, 20 (23%) demonstrated occult metastatic disease. Male gender, tumor size, perineural invasion, and occult metastatic disease were individually associated with higher rates of loco-regional recurrence. There was no significant difference in loco-regional recurrence between those who underwent elective neck dissection and those who did not (HR=0.76, p=0.52). On cost analysis, neck dissection was not associated with any significant difference in Medicare payments. CONCLUSIONS: The high rate of occult metastasis (23%) following elective neck dissection, which did not confer additional healthcare costs, leads to the recommendation of elective neck dissection in patients with cT1N0 oral tongue squamous cell carcinoma.
PURPOSE: We sought to examine prognostic and therapeutic implications, including cost-effectiveness, of elective neck dissection in the management of patients with clinically-determined T1N0 oral tongue carcinoma. MATERIALS AND METHODS: A retrospective review of patients with cT1N0 oral tongue squamous cell carcinoma who underwent surgical extirpation of primary tumor, with or without elective neck dissection, at UCLA Medical Center from 1990 to 2009 was performed. Cox proportional hazards regression was used to assess effects of variables on time to first loco-regional recurrence. A healthcare costs analysis of elective neck dissection was performed by querying the SEER-Medicare linked database. RESULTS: Of the 123 patients identified with cT1N0 squamous cell carcinoma of the oral tongue, 88 underwent elective neck dissection at the time of tumor resection while 35 did not. For all patients, disease-free survival at 3, 5, and 10 years was 93%, 82%, and 79%. Of the 88 patients undergoing elective neck dissection, 20 (23%) demonstrated occult metastatic disease. Male gender, tumor size, perineural invasion, and occult metastatic disease were individually associated with higher rates of loco-regional recurrence. There was no significant difference in loco-regional recurrence between those who underwent elective neck dissection and those who did not (HR=0.76, p=0.52). On cost analysis, neck dissection was not associated with any significant difference in Medicare payments. CONCLUSIONS: The high rate of occult metastasis (23%) following elective neck dissection, which did not confer additional healthcare costs, leads to the recommendation of elective neck dissection in patients with cT1N0 oral tongue squamous cell carcinoma.
Authors: Eric J Moore; Michael L Hinni; Kerry D Olsen; Daniel L Price; Rebecca R Laborde; Jared C Inman Journal: Otolaryngol Head Neck Surg Date: 2012-02-15 Impact factor: 3.497
Authors: Raymond King Yin Tsang; Joseph Chun Kit Chung; Victor Shing Howe To; Jimmy Yu Wai Chan; Wai Kuen Ho; William Ignace Wei Journal: Head Neck Date: 2010-12-06 Impact factor: 3.147
Authors: Christopher J O'Brien; Christopher S Lauer; Susanne Fredricks; Anthony R Clifford; Edward B McNeil; Jai S Bagia; Christina Koulmandas Journal: Head Neck Date: 2003-11 Impact factor: 3.147
Authors: Donald G Sessions; Gershon J Spector; Jason Lenox; Bruce Haughey; Clifford Chao; James Marks Journal: Laryngoscope Date: 2002-04 Impact factor: 3.325
Authors: Joseph R Acevedo; Katherine E Fero; Bayard Wilson; Assuntina G Sacco; Loren K Mell; Charles S Coffey; James D Murphy Journal: J Clin Oncol Date: 2016-11-10 Impact factor: 44.544
Authors: Evangelia Katsoulakis; Jonathan E Leeman; Benjamin H Lok; Weiji Shi; Zhigang Zhang; Jillian C Tsai; Sean M McBride; Eric J Sherman; Marc Cohen; Richard Wong; Ian Ganly; Nancy Y Lee; Nadeem Riaz Journal: Laryngoscope Date: 2018-04-10 Impact factor: 3.325